Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021

BUY
$251.87 - $278.14 $455,632 - $503,155
1,809 New
1,809 $499,000
Q4 2020

Feb 10, 2021

SELL
$186.91 - $214.42 $4.65 Million - $5.34 Million
-24,888 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$167.03 - $201.3 $898,120 - $1.08 Million
5,377 Added 27.56%
24,888 $4.69 Million
Q2 2020

Aug 10, 2020

SELL
$113.31 - $182.44 $76,937 - $123,876
-679 Reduced 3.36%
19,511 $3.24 Million
Q1 2020

May 12, 2020

SELL
$104.32 - $195.28 $45,692 - $85,532
-438 Reduced 2.12%
20,190 $2.55 Million
Q4 2019

Feb 06, 2020

SELL
$163.48 - $173.61 $2.58 Million - $2.74 Million
-15,792 Reduced 43.36%
20,628 $3.49 Million
Q3 2019

Nov 08, 2019

BUY
$159.77 - $178.1 $502,955 - $560,658
3,148 Added 9.46%
36,420 $6.12 Million
Q2 2019

Aug 12, 2019

BUY
$144.16 - $172.9 $420,947 - $504,868
2,920 Added 9.62%
33,272 $5.75 Million
Q1 2019

May 10, 2019

BUY
$123.7 - $156.3 $2.02 Million - $2.55 Million
16,341 Added 116.63%
30,352 $4.64 Million
Q4 2018

Feb 08, 2019

SELL
$120.82 - $174.09 $631,042 - $909,272
-5,223 Reduced 27.16%
14,011 $1.77 Million
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $83,164 - $93,381
496 Added 2.65%
19,234 $3.34 Million
Q2 2018

Aug 09, 2018

SELL
$160.33 - $189.41 $72,789 - $85,992
-454 Reduced 2.37%
18,738 $3.36 Million
Q1 2018

May 15, 2018

SELL
$161.53 - $178.11 $399,302 - $440,287
-2,472 Reduced 11.41%
19,192 $3.11 Million
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $1.54 Million - $1.71 Million
10,412 Added 92.53%
21,664 $3.46 Million
Q3 2017

Nov 14, 2017

SELL
$149.47 - $160.56 $3.07 Million - $3.3 Million
-20,532 Reduced 64.6%
11,252 $1.7 Million
Q2 2017

Aug 07, 2017

BUY
N/A
31,784
31,784 $4.9 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.